1. Most Discussed
  2. Gainers & Losers
NRT 4.2¢

otc products

  1. munch

    3,567 posts.
    Hmmm, I guess if Phenoxodiol proves a success along with NV-04 and NV-07a then the OTC products could become a supplement used by most older people throughout the world. Imagine the advertising Novogen could do if these clinical trials work well... plus they have the patents soon to block compeditors. The US$500m Soy Isoflavone supplement market in the US could multiply rapidly if people relate positive success in NV-06, NV-04 to the supplements. Keep in mind that Dr Kelly stated at the Yale presentation that Novogen believes the OTC products are already a "cancer inhibitor" people can take before they get cancer.

    "The Novogen group of companies is continuing also to expand its consumer products franchise with the sales of Promensil, Trinovin and Rimostil around the world. Clinical support for these products is being amassed from specific clinical trials such as the recent double blind placebo controlled Promensil trial showing a significant reduction in hot flushing during menopause. Further persuasive evidence of the importance of these essential dietary supplements to human the health and well-being will be evident from the success of the related-compound drug clinical trials now underway. "

DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top